News
Grifols’ Tavlesse receives NICE recommendation
Grifols has announced that its treatment for adults with chronic immune thrombocytopenia (ITP), Tavlesse – also known as fostamatinib – is now recommended by the National Institute for Health and Care Excellence (NICE).